Search Within

GDMT, Medicine

  1. "Biostatistics Service"
Formats
  1. Journal Article (205)
  2. Meeting Abstract (107)
  3. Book Section (1)
  4. Research Letter (1)
Groups
  1. Biostatistics Service (314)
  2. Department of Medicine (314)
  3. Epidemiology and Biostatistics (314)
  4. Gynecology Disease Management Team (314)
  5. Solid Tumor Oncology Division (310)
  6. Gynecologic Medicine Service (299)

More Groups

People
  1. Alexia Iasonos (186)
  2. Carol Aghajanian (143)
  3. Qin Zhou (143)
  4. Dennis Chi (81)
  5. Martee Hensley (80)
  6. Nadeem Abu-Rustum (78)

More People

Years
  1. 2025 (8)
  2. 2024 (25)
  3. 2023 (30)
  4. 2022 (29)
  5. 2021 (17)
  6. 2020 (24)

More Years

Publications
  1. Gynecologic Oncology (84)
  2. Journal of Clinical Oncology (74)
  3. International Journal of Gynecological Cancer (34)
  4. Cancer (12)
  5. Clinical Cancer Research (11)
  6. Breast Cancer Research and Treatment (7)

More Publications

Publishers
  1. Elsevier Inc. (93)
  2. American Society of Clinical Oncology (82)
  3. Lippincott Williams & Wilkins (36)
  4. American Association for Cancer Research (21)
  5. Wiley Blackwell (16)
  6. Springer (13)

More Publishers

Results (314)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Nacev, B. A.; Rosenbaum, E.; Thornton, K. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended release (ONA-XR) in progesterone receptor positive (PR+) recurrent granulosa cell (GCT), low-grade serous ovarian (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Zhou, Q.; Iasonos, A.; Girshman, J.; Shah, P.; Jang, D.; Kyi, C.; Cohen, S. M.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Single agent PD-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Lumish, M. A.; Sinopoli, J. C.; Weiss, J. A.; Shia, J.; Stadler, Z. K.; Yaeger, R.; Smith, J. J.; Saltz, L. B.; El Dika, I. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Genetic ancestry correlates with somatic differences in a real-world clinical cancer sequencing cohort
    Journal Article

    Arora, K.; Tran, T. N.; Kemel, Y.; Mehine, M.; Liu, Y. L.; Nandakumar, S.; Smith, S. A.; Brannon, A. R.; Ostrovnaya, I.; Stopsack, K. H.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study
    Meeting Abstract

    Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • MAPK pathway genetic alterations are associated with prolonged overall survival in low-grade serous ovarian carcinoma
    Journal Article

    Manning-Geist, B.; Gordhandas, S.; Liu, Y. L.; Zhou, Q.; Iasonos, A.; Da Cruz Paula, A.; Mandelker, D.; Long Roche, K.; Zivanovic, O.; Maio, A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles
    Journal Article

    Manning-Geist, B. L.; Liu, Y. L.; Devereaux, K. A.; Da Cruz Paula, A.; Zhou, Q. C.; Ma, W.; Selenica, P.; Ceyhan-Birsoy, O.; Moukarzel, L. A.; Hoang, T.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: A feasibility study
    Journal Article

    Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
    Breast Cancer Research and Treatment (2022)

    Fulltext@MSK | Save